Advertisement
Australia markets close in 3 hours 50 minutes
  • ALL ORDS

    8,042.10
    -16.50 (-0.20%)
     
  • ASX 200

    7,773.50
    -14.80 (-0.19%)
     
  • AUD/USD

    0.6669
    +0.0011 (+0.16%)
     
  • OIL

    78.80
    +1.08 (+1.39%)
     
  • GOLD

    2,354.50
    +20.00 (+0.86%)
     
  • Bitcoin AUD

    103,020.58
    -755.93 (-0.73%)
     
  • CMC Crypto 200

    1,484.46
    +0.26 (+0.02%)
     
  • AUD/EUR

    0.6130
    +0.0005 (+0.08%)
     
  • AUD/NZD

    1.0818
    +0.0002 (+0.02%)
     
  • NZX 50

    11,711.15
    -44.85 (-0.38%)
     
  • NASDAQ

    18,808.35
    +184.95 (+0.99%)
     
  • FTSE

    8,317.59
    -21.64 (-0.26%)
     
  • Dow Jones

    39,069.59
    +4.29 (+0.01%)
     
  • DAX

    18,774.71
    +81.34 (+0.44%)
     
  • Hang Seng

    18,930.76
    +103.41 (+0.55%)
     
  • NIKKEI 225

    38,813.13
    -86.89 (-0.22%)
     

The Bad News Heading Into AbbVie's First-Quarter Earnings Report

The Bad News Heading Into AbbVie's First-Quarter Earnings Report

AbbVie stock has slumped 9% off its record high in March and is facing increasingly steep competition for its biggest moneymaker, Humira.